SCHEDULE: L1 Capital Discloses 9.99% Stake in Baird Medical

L1 Capital Global Opportunities Master Fund, Ltd. has reported beneficial ownership of 9.99% of Baird Medical Investment Holdings Ltd.'s ordinary shares, primarily through convertible notes.

Summary

• L1 Capital Global Opportunities Master Fund, Ltd. has filed a Schedule 13G, indicating it now beneficially owns 9.99% of Baird Medical Investment Holdings Ltd.'s ordinary shares.
• The reported ownership of 3,551,868 shares includes 110,070 directly held shares and 3,441,798 shares issuable upon conversion of a Senior 8% Original Issue Discount Convertible Promissory Note.
• An additional 2,475,826 shares issuable from another convertible note are not included due to a 9.99% beneficial ownership limitation.
• The percentage of class ownership is based on 33,612,440 ordinary shares outstanding as of September 24, 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership that has reached a reporting threshold. It does not contain operational or financial performance data.

Positives

• L1 Capital has taken a significant stake, potentially signaling confidence in Baird Medical's future prospects.
• The disclosure is transparent and adheres to regulatory requirements.

Negatives

• The filing does not provide any information on Baird Medical's operational performance or financial health.
• The significant portion of shares held via convertible notes introduces complexity and potential dilution.

Risks

• The beneficial ownership is subject to a 9.99% limitation, meaning further increases in ownership may be restricted or require additional filings.
• The value of the convertible notes is tied to the performance and stock price of Baird Medical, introducing investment risk.
• Potential for future share price volatility if L1 Capital decides to adjust its position.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Baird Medical's future performance. It solely reports on L1 Capital's ownership stake.

Management Comments

• David Feldman, Director of L1 Capital Global Opportunities Master Fund, Ltd., certified that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Industry Context

StockSavvy.ai notes that significant stake building by investment funds, especially through convertible instruments, is a common strategy in the healthcare and medical technology sectors, often indicating a belief in growth potential or a desire for influence.

Management Changes

Stakeholder Impact

• Shareholders: May see increased volatility or potential for strategic shifts due to L1 Capital's significant stake.
• Management of Baird Medical: May face increased engagement or influence from L1 Capital.

Next Steps

• L1 Capital will continue to monitor its beneficial ownership percentage in Baird Medical Investment Holdings Ltd.
• Baird Medical Investment Holdings Ltd. may be subject to increased scrutiny or engagement from L1 Capital given its significant stake.

Key Dates

Keywords

Baird Medical Investment Holdings, L1 Capital Global Opportunities Master Fund, Schedule 13G, Beneficial Ownership, Convertible Notes, Ordinary Shares, Securities Exchange Act